An autoimmune disease is a condition in which your immune system mistakenly attacks your own healthy cells and tissues. Roughly 8% to 10% of people worldwide are affected. There are more than 80 recognized autoimmune diseases, ranging from conditions that target a single organ (like the thyroid) to those that affect the entire body (like lupus).
How the Immune System Turns on Itself
Your immune system is built around a concept called “tolerance,” the ability to tell the difference between your own cells and foreign invaders like bacteria or viruses. In autoimmune disease, that tolerance breaks down. Immune cells that should ignore your own tissue instead recognize it as a threat and mount an attack.
Two types of immune cells drive the damage. T cells, which normally destroy infected cells, begin targeting healthy tissue directly. B cells, which normally produce antibodies against germs, start producing “autoantibodies” that lock onto your own proteins. These autoantibodies can damage organs, trigger inflammation, and recruit even more immune cells to join the attack. The result is a self-sustaining cycle of tissue destruction that, without treatment, tends to worsen over time.
What Causes It
No single factor causes autoimmune disease. It develops when genetic susceptibility meets the right environmental trigger.
On the genetic side, the strongest link involves a set of genes that control how your immune cells identify threats. Subtle variations in these genes change the shape of the molecular “groove” where immune cells inspect fragments of protein. When the groove is shaped in a way that makes your own proteins look suspicious, the risk of autoimmunity rises. Specific variants are tied to specific diseases: one set increases the risk of rheumatoid arthritis, another raises the odds of type 1 diabetes.
But genes alone don’t seal your fate. Environmental triggers push a primed immune system over the edge. The most studied trigger is Epstein-Barr virus, the virus behind mono. Longitudinal studies of military personnel found that people who later developed lupus had elevated antibodies to Epstein-Barr years before their first symptoms appeared. Parts of the virus structurally resemble human proteins, so the immune response against the virus can accidentally cross-react with the body’s own tissue, a process called molecular mimicry. Similar post-infection autoimmune reactions have been documented after COVID-19, including cases of Guillain-Barré syndrome and systemic autoimmunity.
The gut plays a role too. Changes in gut bacteria can weaken the intestinal barrier and impair regulatory immune cells that normally keep autoimmune responses in check. Dietary factors like gluten can worsen intestinal permeability in genetically susceptible people, and elevated iron intake in infancy has been linked to a higher risk of type 1 diabetes.
Why Women Are Affected More Often
Women face up to four times the risk of autoimmune disease compared to men. In lupus and Sjögren’s disease, the disparity is even steeper. Several factors contribute. Sex hormones like estrogen can amplify immune cell activity, while androgens (more abundant in men) tend to dampen it. The X chromosome carries a high density of immune-related genes, and having two copies may increase the chance of immune dysregulation.
There’s also an evolutionary angle. Women appear to have a conserved tendency toward stronger B cell activation and higher antibody production, traits that likely evolved to better protect offspring from infection. The tradeoff is a higher baseline risk of antibody-driven autoimmune conditions.
The Most Common Autoimmune Diseases
The five most prevalent autoimmune diseases in the United States, based on a Mayo Clinic study, are rheumatoid arthritis, psoriasis, type 1 diabetes, Graves’ disease, and autoimmune thyroiditis (Hashimoto’s). Beyond these, some of the most widely recognized include lupus, multiple sclerosis, inflammatory bowel disease (Crohn’s and ulcerative colitis), celiac disease, and myasthenia gravis.
Some of these target a single organ. Graves’ disease and Hashimoto’s both affect the thyroid but in opposite directions: Graves’ causes overactivity, Hashimoto’s causes underactivity. Type 1 diabetes destroys the insulin-producing cells of the pancreas. Others, like lupus and rheumatoid arthritis, are systemic, meaning they can affect joints, skin, kidneys, blood vessels, and other organs simultaneously.
Common Symptoms
Symptoms depend heavily on which part of the body is under attack, but inflammation is the common thread. Redness, swelling, heat, and pain show up across nearly every autoimmune condition, whether it’s the joints in rheumatoid arthritis or the skin in psoriasis. Many people also experience fatigue, muscle aches, and low-grade fever, symptoms vague enough that they often overlap with other illnesses and delay diagnosis.
Flares and remissions are typical. You might feel fine for weeks or months, then experience a period where symptoms intensify. Stress, infections, and hormonal shifts are common triggers for flares, though they vary from person to person.
How Autoimmune Diseases Are Diagnosed
There is no single test that confirms autoimmune disease. Diagnosis typically involves a combination of blood work, symptom history, and sometimes imaging or biopsy. Three blood markers come up frequently in the screening process:
- ANA (antinuclear antibody) test: Detects antibodies that target the nucleus of your own cells. A positive result is common in lupus and several other autoimmune conditions, but it can also be positive in healthy people, so it’s a starting point rather than a definitive answer.
- CRP (C-reactive protein): A protein your liver releases in response to inflammation. Levels above about 1.0 mg/dL suggest active inflammation somewhere in the body. Elevated CRP is seen in lupus, rheumatoid arthritis, and vasculitis, among others.
- ESR (erythrocyte sedimentation rate): Another general marker of inflammation, often used alongside CRP to gauge how active the disease is.
None of these markers pinpoint a specific autoimmune disease on their own. Your doctor will interpret them alongside your symptoms and additional, more targeted tests. Reaching a definitive diagnosis can take months or even years, particularly when symptoms are nonspecific or overlap between conditions.
Treatment Options
Autoimmune diseases are chronic, meaning they can be managed but not cured. Treatment aims to reduce inflammation, control the overactive immune response, and prevent organ damage. The approach usually follows a progression from broader to more targeted therapies.
Corticosteroids are often the first line for acute flares. They suppress the immune system broadly and reduce inflammation quickly, but long-term use carries significant side effects, so doctors try to taper them as soon as possible. Disease-modifying drugs (DMARDs) work more slowly but help control the disease over months and years by dialing down the immune response more sustainably.
Biologic therapies represent a more targeted approach. Rather than suppressing the whole immune system, they block specific molecules driving the attack. Some neutralize inflammatory signaling proteins. Others deplete B cells, the immune cells responsible for producing autoantibodies. Still others block the communication signals that activate T cells. These therapies have transformed outcomes for conditions like rheumatoid arthritis and lupus, particularly in patients who don’t respond well to conventional drugs. Intravenous immunoglobulin (IVIG), a preparation of donated antibodies, is another option that works by neutralizing harmful autoantibodies and recalibrating immune cell behavior.
One of the most watched developments involves a therapy originally designed for certain blood cancers. It uses a patient’s own immune cells, genetically engineered to target and eliminate the B cells producing autoantibodies. Early results in patients with severe, treatment-resistant lupus and other conditions have shown complete remission. However, out of 119 registered clinical trials worldwide, the vast majority are still in early phases testing safety and dosing. Only a handful have advanced to late-stage evaluation, so it remains years from widespread use.
Long-Term Health Impact
Living with autoimmune disease means managing not just the primary condition but also the downstream effects on overall health. In the United Kingdom, autoimmune diseases ranked as the sixth or seventh most common cause of death among women under 75, according to a study published in the American Journal of Public Health. For women aged 15 to 54, the ranking was similarly high. People with one autoimmune disease are also more likely to develop a second; death certificates in the same study showed that more than 300 individuals had two separate autoimmune diagnoses listed.
The chronic inflammation that defines these diseases raises the risk of cardiovascular problems, organ damage, and infections, the last made worse by immune-suppressing treatments. Quality of life is a real concern as well: persistent fatigue, pain, and unpredictable flares can affect work, relationships, and mental health. Early diagnosis and consistent treatment significantly improve long-term outcomes, making it possible for many people to live full, active lives despite carrying an autoimmune condition.